Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastases, Neoplasm|Colorectal Neoplasms|Esophageal Neoplasms|Stomach Neoplasms|Pancreatic Neoplasms|Breast Neoplasms|Melanoma|Sarcoma|Gastrointestinal Neoplasms|Lung Neoplasms|Liver Neoplasms|Cholangiocarcinoma
Interventions: DRUG: MTC-DOX for Injection|PROCEDURE: Chemotherapy
Sponsor: FeRx